Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance AP Magiorakos, A Srinivasan, RB Carey, Y Carmeli, ME Falagas, ... Clinical microbiology and infection 18 (3), 268-281, 2012 | 14770 | 2012 |
Comparison of PubMed, Scopus, web of science, and Google scholar: strengths and weaknesses ME Falagas, EI Pitsouni, GA Malietzis, G Pappas The FASEB journal 22 (2), 338-342, 2008 | 5164 | 2008 |
Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections ME Falagas, SK Kasiakou, LD Saravolatz Clinical infectious diseases 40 (9), 1333-1341, 2005 | 2297 | 2005 |
Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis G Pappas, N Roussos, ME Falagas International journal for parasitology 39 (12), 1385-1394, 2009 | 1468 | 2009 |
Obesity and infection ME Falagas, M Kompoti The Lancet infectious diseases 6 (7), 438-446, 2006 | 1098 | 2006 |
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies ME Falagas, SK Kasiakou Critical care 10, 1-13, 2006 | 1064 | 2006 |
Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review PI Rafailidis, EG Mourtzoukou, IC Varbobitis, ME Falagas Virology journal 5, 1-7, 2008 | 803 | 2008 |
Comparison of SCImago journal rank indicator with journal impact factor ME Falagas, VD Kouranos, R Arencibia-Jorge, DE Karageorgopoulos The FASEB journal 22 (8), 2623-2628, 2008 | 776 | 2008 |
Current control and treatment of multidrug-resistant Acinetobacter baumannii infections DE Karageorgopoulos, ME Falagas The Lancet infectious diseases 8 (12), 751-762, 2008 | 761 | 2008 |
Fosfomycin ME Falagas, EK Vouloumanou, G Samonis, KZ Vardakas Clinical microbiology reviews 29 (2), 321-347, 2016 | 709 | 2016 |
Extended-spectrum β-lactamase-producing organisms ME Falagas, DE Karageorgopoulos Journal of Hospital infection 73 (4), 345-354, 2009 | 696 | 2009 |
β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis DE Karageorgopoulos, EK Vouloumanou, F Ntziora, A Michalopoulos, ... Clinical Infectious Diseases 52 (6), 750-770, 2011 | 695 | 2011 |
The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa ME Falagas, PK Koletsi, IA Bliziotis Journal of medical microbiology 55 (12), 1619-1629, 2006 | 693 | 2006 |
Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review ME Falagas, AC Kastoris, AM Kapaskelis, DE Karageorgopoulos The Lancet infectious diseases 10 (1), 43-50, 2010 | 684 | 2010 |
Deaths attributable to carbapenem-resistant Enterobacteriaceae infections ME Falagas, GS Tansarli, DE Karageorgopoulos, KZ Vardakas Emerging infectious diseases 20 (7), 1170, 2014 | 666 | 2014 |
Epidemiology of constipation in Europe and Oceania: a systematic review G Peppas, VG Alexiou, E Mourtzoukou, ME Falagas BMC gastroenterology 8, 1-7, 2008 | 596 | 2008 |
Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era? ME Falagas, IA Bliziotis International journal of antimicrobial agents 29 (6), 630-636, 2007 | 569 | 2007 |
Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations J Ariza, M Bosilkovski, A Cascio, JD Colmenero, MJ Corbel, ME Falagas, ... PLOS medicine 4 (12), e317, 2007 | 543 | 2007 |
Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis KA Polyzos, AA Konstantelias, ME Falagas Ep Europace 17 (5), 767-777, 2015 | 529 | 2015 |
Psychosocial consequences of infectious diseases G Pappas, IJ Kiriaze, P Giannakis, ME Falagas Clinical microbiology and infection 15 (8), 743-747, 2009 | 481 | 2009 |